SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-260619
Filing Date
2022-10-11
Accepted
2022-10-11 16:13:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d369171d424b5.htm 424B5 407671
2 GRAPHIC g369171g03p01.jpg GRAPHIC 42121
  Complete submission text file 0001193125-22-260619.txt   459831
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267702 | Film No.: 221304212
SIC: 2834 Pharmaceutical Preparations